Search Within

Tarun Kewalramani

Formats
  1. Meeting Abstract (38)
  2. Journal Article (24)
  3. Book Section (1)
Groups
  1. Department of Medicine (55)
  2. Hematologic Malignancies, Division of (53)
  3. Center for Hematologic Malignancies (47)
  4. Lymphoma (31)
  5. Survivorship Research (27)
  6. Radiation Oncology, Department of (24)

More Groups

People
  1. Stephen Nimer (40)
  2. Craig Moskowitz (33)
  3. Andrew Zelenetz (29)
  4. Joachim Yahalom (23)
  5. Julie Feldstein (16)
  6. Raymond Comenzo (16)

More People

Years
  1. 2010 (3)
  2. 2009 (3)
  3. 2008 (6)
  4. 2007 (8)
  5. 2006 (7)
  6. 2005 (7)

More Years

Publications
  1. Blood (35)
  2. Bone Marrow Transplantation (5)
  3. British Journal of Haematology (5)
  4. Journal of Clinical Oncology (4)
  5. Biology of Blood and Marrow Transplantation (2)
  6. International Journal of Radiation Oncology, Biology, Physics (2)

More Publications

Publishers
  1. American Society of Hematology (35)
  2. Nature Publishing Group (6)
  3. John Wiley & Sons (5)
  4. American Society of Clinical Oncology (4)
  5. Elsevier Inc. (4)
  6. Oxford University Press (3)

More Publishers

Results (63)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Palifermin for oral mucositis after intensive therapy for hematologic cancers
    Journal Article

    Spielberger, R.; Stiff, P.; Bensinger, W.; Gentile, T.; Weisdorf, D.; Kewalramani, T.; Shea, T.; Yanovich, S.; Hansen, K.; Noga, S.; more...
    New England Journal of Medicine (2004)

    Fulltext@MSK | Save
  • Risk-adpated high dose chemoradiotherapy and ASCT for patients with relapsed and primary refractory Hodgkin's disease: An intent to treat analysis
    Meeting Abstract

    Moskowitz, C. H.; Kewalramani, T.; Nimer, S. D.; Rice, R. D.; Rosenzweig, L.; Horwitz, S.; Noy, A.; O'connor, O.; Portlock, C. S.; Straus, D.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • A phase II study of stem cell mobilization with IV melphalan (60 mg/M-2) + G-CSF in multiple myeloma
    Meeting Abstract

    Gupta, S.; Costello, S.; Zhou, P.; Reich, L.; Hassoun, H.; Klimek, V.; Kewalramani, T.; Dhodapkar, M.; Fleisher, M.; Hedvat, C.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Palifermin treatment of mucositis in transplant patients reduces health resource use: Phase 3 results
    Meeting Abstract

    Emmanouilides, C.; Spielberger, R.; Stiff, P.; Rong, A.; Isitt, J.; Bensinger, W.; Weisdorf, D.; Gentile, T.; Kewalramani, T.; Shea, T.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone (AD) followed by thalidomide and dexamethasone (TD) as initial therapy for symptomatic patients with multiple myeloma
    Meeting Abstract

    Comenzo, R. L.; Hassoun, H.; Reich, L.; Klimek, V.; Kewalramani, T.; Dhodapkar, M.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Fleisher, M.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin's lymphoma
    Journal Article

    Zelenetz, A. D.; Hamlin, P.; Kewalramani, T.; Yahalom, J.; Nimer, S.; Moskowitz, C. H.
    Annals of Oncology (2003)

    Fulltext@MSK | Save
  • Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma
    Journal Article

    Kewalramani, T.; Nimer, S. D.; Zelenetz, A. D.; Malhotra, S.; Qin, J.; Yahalom, J.; Moskowitz, C. H.
    Bone Marrow Transplantation (2003)

    Fulltext@MSK | Save
  • Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma
    Journal Article

    Hamlin, P. A.; Zelenetz, A. D.; Kewalramani, T.; Qin, J.; Satagopan, J. M.; Verbel, D.; Noy, A.; Portlock, C. S.; Straus, D. J.; Yahalom, J.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease
    Journal Article

    Dhodapkar, M. V.; Osman, K.; Teruya-Feldstein, J.; Filippa, D.; Hedvat, C. V.; Iversen, K.; Kolb, D.; Geller, M. D.; Hassoun, H.; Kewalramani, T.; more...
    Cancer Immunity (2003)

    Fulltext@MSK | Save
  • Stem cell transplantation for aggressive non-Hodgkin's lynmphoma
    Book Section

    Kewalramani, T.; Moskowitz, C. H.
    In Grossbard, M. L. (Eds.) Malignant Lymphomas (2002)

    Fulltext@MSK | Save